MENU
LPCN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lipocine (LPCN) Earnings Date & Reports
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology... Show more
Industry: #Pharmaceuticals Other
A.I. Advisor
published Earnings
LPCN is expected to report earnings to rise 21.87% to -38 cents per share on November 05
Q3'26
Est.
$-0.39
Q2'26
Beat
by $0.12
Q1'26
Missed
by $0.07
Q1'23
Missed
by $0.01
Q4'22
Missed
by $0.31
The last earnings report on August 04 showed earnings per share of -31 cents, beating the estimate of -43 cents. With 260.38K shares outstanding, the current market capitalization sits at 13.19M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
14
Web
https://www.lipocine.com